Beneficial effect of CV-4151 (Isbogrel), a thromboxane A 2 synthase inhibitor, in a rat middle cerebral artery thrombosis model

By Imura Y.   Kiyota Y.   Nagai Y.   Terashita Z.-i.   Nishikawa K.  

Thrombosis Research, Vol. 79, Iss. 1, 1995-07 ,pp. : 95-107

Elsevier

Access to resources Recommend Favorite

Transcellular Formation of Thromboxane A 2 in Mixed Incubations of Endothelial Cells and Aspirin-Treated Platelets Strongly Depends on the Prostaglandin I-Synthase Activity

By Camacho M.   Vila L.  

Thrombosis Research, Vol. 99, Iss. 2, 2000-07 ,pp. : 155-164

Elsevier

Access to resources Recommend Favorite

Habitual smoking causes an abnormality in platelet thromboxane A₂ metabolism and results in an altered susceptibility to aspirin effects

By Weber Artur-Aron   Liesener Sven   Schanz Andrea   Hohlfeld Thomas   Schror Karsten  

Platelets, Vol. 11, Iss. 3, 2000-05 ,pp. : 177-182

Informa Healthcare

Access to resources Recommend Favorite

Brief communication the combination of thrombin inhibitor and thromboxane synthase inhibitor on experimental thrombosis and bleeding

By Kawai H.   Tamao Y.  

Thrombosis Research, Vol. 80, Iss. 5, 1995-12 ,pp. : 429-434

Elsevier

Access to resources Recommend Favorite

Cyclooxygenase-2 and thromboxane synthase in non-endocrine and endocrine tumors: A review

By Onguru Onder   Casey Mary   Kajita Sabine   Nakamura Nobuki   Lloyd Ricardo  

Endocrine Pathology, Vol. 16, Iss. 4, 2005-12 ,pp. : 253-277

Humana Press, Inc

Access to resources Recommend Favorite